4.6 Article

Tachycardiomyopathy entails a dysfunctional pattern of interrelated mitochondrial functions

Journal

BASIC RESEARCH IN CARDIOLOGY
Volume 117, Issue 1, Pages -

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00395-022-00949-0

Keywords

Tachycardiomyopathy; Mitochondria; Redox; Acetylome

Funding

  1. Projekt DEAL
  2. University Hospital Regensburg
  3. Marga-and-Walter-Boll-Foundation [220-05.01-15]
  4. German Cardiac Society (DGK-Deutsche Gesellschaft fur Kardiologie, Herz-und Kreislaufforschung)
  5. German Heart Foundation/German Foundation of Heart Research
  6. German Society of Internal Medicine
  7. F. Thyssen Foundation [Az 10.19.2.026MN]
  8. Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [WA 2539/8-1, SFB 1350, 387509280]

Ask authors/readers for more resources

Tachycardiomyopathy is a reversible left ventricular dysfunction caused by rapid heart rate. This study used rabbit models and induced pluripotent stem cell-derived cardiomyocytes to investigate the mitochondrial dysfunctions in tachycardiomyopathy. The findings show depletion of tricarboxylic acid cycle intermediates, altered redox balance, and mitochondrial morphological changes. These patterns diverge from characteristic signs of other heart failure etiologies.
Tachycardiomyopathy is characterised by reversible left ventricular dysfunction, provoked by rapid ventricular rate. While the knowledge of mitochondria advanced in most cardiomyopathies, mitochondrial functions await elucidation in tachycardiomyopathy. Pacemakers were implanted in 61 rabbits. Tachypacing was performed with 330 bpm for 10 days (n = 11, early left ventricular dysfunction) or with up to 380 bpm over 30 days (n = 24, tachycardiomyopathy, TCM). In n = 26, pacemakers remained inactive (SHAM). Left ventricular tissue was subjected to respirometry, metabolomics and acetylomics. Results were assessed for translational relevance using a human-based model: induced pluripotent stem cell derived cardiomyocytes underwent field stimulation for 7 days (TACH-iPSC-CM). TCM animals showed systolic dysfunction compared to SHAM (fractional shortening 37.8 +/- 1.0% vs. 21.9 +/- 1.2%, SHAM vs. TCM, p < 0.0001). Histology revealed cardiomyocyte hypertrophy (cross-sectional area 393.2 +/- 14.5 mu m(2) vs. 538.9 +/- 23.8 mu m(2), p < 0.001) without fibrosis. Mitochondria were shifted to the intercalated discs and enlarged. Mitochondrial membrane potential remained stable in TCM. The metabolite profiles of ELVD and TCM were characterised by profound depletion of tricarboxylic acid cycle intermediates. Redox balance was shifted towards a more oxidised state (ratio of reduced to oxidised nicotinamide adenine dinucleotide 10.5 +/- 2.1 vs. 4.0 +/- 0.8, p < 0.01). The mitochondrial acetylome remained largely unchanged. Neither TCM nor TACH-iPSC-CM showed relevantly increased levels of reactive oxygen species. Oxidative phosphorylation capacity of TCM decreased modestly in skinned fibres (168.9 +/- 11.2 vs. 124.6 +/- 11.45 pmol center dot O-2 center dot s(-1)center dot mg(-1) tissue, p < 0.05), but it did not in isolated mitochondria. The pattern of mitochondrial dysfunctions detected in two models of tachycardiomyopathy diverges from previously published characteristic signs of other heart failure aetiologies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available